MarginsXMarginsX
Home › Data Desk › State Street Corp passes 5.0% of Recursion Pharmaceuticals Inc.

MarginsX Data Desk · 13G holders · Artificial intelligence · Carbon and clean energy credits · Oncology

State Street Corp passes 5.0% of Recursion Pharmaceuticals Inc.

In a Schedule 13G filed Nov 10, 2026, State Street Corp reported 30.0 million shares of Recursion Pharmaceuticals Inc. (RXRX) as of Sep 30, 2026, 5.6% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 10, 2026.

Line chart of Recursion Pharmaceuticals Inc. (RXRX) daily closes from Jul 6, 2026 to Nov 10, 2026, with the 13G filing on Nov 10, 2026 marked.

The threshold

A passive holder files this schedule once it owns more than 5.0% of a class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)

The stock

The Nasdaq screener puts its market value at $2.0B. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/RXRX)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
FilerState Street CorpSource2026-11-10
Level5 %Source2026-11-10
NameRecursion Pharmaceuticals Inc.Source2026-11-13
FormSchedule 13GSource2026-11-10
FiledNov 10, 2026Source2026-11-10
Shares30,001,137 sharesSource2026-11-10
WhoRecursion Pharmaceuticals Inc. (RXRX)Source2026-11-13
SymbolRXRXSource2026-11-13
Event dateSep 30, 2026Source2026-11-10
Pct5.6 %Source2026-11-10
Cap1,983,488,239 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS